Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2

To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe to prevent infection with SARS-CoV-2 and development of COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

This is a protocol.

Share/Save
Health topics: